HomeNDC LookupRxCUI directory › RxCUI 1431642

4 ML golimumab 12.5 MG/ML Injection — RxCUI 1431642

RxNorm drug concept · Semantic clinical drug
RxCUI 1431642 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1431642
Official name4 ML golimumab 12.5 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asgolimumab 50 MG per 4 ML Injection; golimumab 50 MG in 4 mL Injection
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)19,229 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Golimumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Golimumab is approved for several inflammatory conditions, and which ones depend on the product you're using. Simponi — the version you inject under your own skin — treats rheumato...
  • What conditions does golimumab actually treat?
  • Before injecting, take the prefilled syringe or autoinjector out of the refrigerator and let it sit at room temperature for at least 30 minutes — don't try to warm it up any other...
  • How do I give myself the Simponi injection at home?
📖 Read our full Golimumab Injection guide →

🕸️ Concept Web — How 4 ML golimumab 12.5 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 4 ML golimumab 12.5 MG/ML Injection RxCUI 1431642

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Golimumab 819300
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Simponi 848161
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Golimumab Injection 1653569
    • Golimumab Injectable Product 1157808
    • Golimumab Injection [Simponi] 1653571
    • Simponi Injectable Product 1182643
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Golimumab 12.5 MG/ML SCDC · 1431639
  • Golimumab Injection SCDF · 1653569
  • Golimumab Injectable Product SCDG · 1157808

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1431642 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
57894-0350-01 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-350-01) / 4 mL in 1... SIMPONI ARIA Janssen Biotech, Inc. 2013-07-19
57894-0350-89 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-350-89) / 4 mL in 1... SIMPONI ARIA Janssen Biotech, Inc. 2013-07-19
Observed labelers: Janssen Biotech, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1602 Golimumab for iv use 1mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.